[{"address1": "3060 Pegasus Park Drive", "address2": "Building 6", "city": "Dallas", "state": "TX", "zip": "75247", "country": "United States", "phone": "310 618 6994", "website": "https://www.fortebiorx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul A.  Wagner Ph.D.", "age": 55, "title": "CEO, President & Chairman", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1030848, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Antony A. Riley CPA", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 652090, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Barbara K. Finck M.D.", "age": 78, "title": "Chief Medical Clinician & Director", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 488057, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Roenfeldt", "title": "Chief Operating Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 27.27, "open": 26.49, "dayLow": 23.08, "dayHigh": 26.875, "regularMarketPreviousClose": 27.27, "regularMarketOpen": 26.49, "regularMarketDayLow": 23.08, "regularMarketDayHigh": 26.875, "payoutRatio": 0.0, "beta": 3.254, "forwardPE": -6.7909813, "volume": 177133, "regularMarketVolume": 177133, "averageVolume": 123852, "averageVolume10days": 214090, "averageDailyVolume10Day": 214090, "bid": 22.76, "ask": 25.88, "bidSize": 1, "askSize": 1, "marketCap": 295760928, "fiftyTwoWeekLow": 4.9, "fiftyTwoWeekHigh": 31.27, "allTimeHigh": 6732.375, "allTimeLow": 4.11, "fiftyDayAverage": 18.5485, "twoHundredDayAverage": 12.33964, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 202346928, "profitMargins": 0.0, "floatShares": 6565492, "sharesOutstanding": 12526935, "sharesShort": 139200, "sharesShortPriorMonth": 427816, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0111, "heldPercentInsiders": 0.04935, "heldPercentInstitutions": 0.90405, "shortRatio": 1.08, "shortPercentOfFloat": 0.013200001, "impliedSharesOutstanding": 12526935, "bookValue": 4.717, "priceToBook": 5.0053, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -51742000, "trailingEps": -0.08, "forwardEps": -3.47667, "lastSplitFactor": "1:25", "lastSplitDate": 1724803200, "enterpriseToEbitda": -3.791, "52WeekChange": 0.20663714, "SandP52WeekChange": 0.14561749, "quoteType": "EQUITY", "currentPrice": 23.61, "targetHighPrice": 75.0, "targetLowPrice": 19.0, "targetMeanPrice": 54.8, "targetMedianPrice": 61.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 93414000, "totalCashPerShare": 7.457, "ebitda": -53382000, "totalDebt": 0, "quickRatio": 7.231, "currentRatio": 7.344, "returnOnAssets": -0.58066005, "returnOnEquity": -1.10722, "freeCashflow": -24480124, "operatingCashflow": -44425000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "FBRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_594626683", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Forte Biosciences, Inc.", "longName": "Forte Biosciences, Inc.", "postMarketTime": 1767400998, "regularMarketTime": 1767387601, "corporateActions": [], "regularMarketChangePercent": -13.4213, "regularMarketPrice": 23.61, "marketState": "CLOSED", "fiftyDayAverageChange": 5.0615005, "fiftyDayAverageChangePercent": 0.27287924, "twoHundredDayAverageChange": 11.270361, "twoHundredDayAverageChangePercent": 0.91334605, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1492090200000, "postMarketChangePercent": 3.557815, "postMarketPrice": 24.45, "postMarketChange": 0.84000015, "regularMarketChange": -3.66, "regularMarketDayRange": "23.08 - 26.875", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 123852, "fiftyTwoWeekLowChange": 18.710001, "fiftyTwoWeekLowChangePercent": 3.8183675, "fiftyTwoWeekRange": "4.9 - 31.27", "fiftyTwoWeekHighChange": -7.66, "fiftyTwoWeekHighChangePercent": -0.24496321, "fiftyTwoWeekChangePercent": 20.663715, "dividendDate": 1592265600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.08, "epsForward": -3.47667, "epsCurrentYear": -4.316, "priceEpsCurrentYear": -5.470343, "displayName": "Forte Biosciences", "trailingPegRatio": null, "__fetch_time": "2026-01-03"}]